- 米国企業
- PRESSURE BIOSCIENCES INC
PRESSURE BIOSCIENCES INCPBIO
時価総額
$49.1万
PER
2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Products, services, other | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
Cost of products and services | - | - | - | 609,054 | 834,012 | 1 | 1 | 1 | 582,854 | 942,383 | 2 |
Research and development | 965,623 | 1 | 952,555 | 1 | 1 | 988,597 | 1 | 1 | 1 | 1 | 969,532 |
Selling and marketing | 714,635 | 752,288 | 721,229 | 745,574 | 872,365 | 1 | 1 | 680,629 | 649,783 | 324,728 | 401,444 |
General and administrative | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 5 | 3 | 4 | 3 |
Total operating costs | - | - | - | - | - | - | - | - | 6 | 6 | 7 |
Operating loss | -3,463,642 | -3,327,192 | -3,338,350 | -3,565,182 | -3,735,653 | -4,647,048 | -4,477,083 | -5,805,534 | -4,585,787 | -4,185,147 | -4,898,289 |
Interest expense, net | - | - | - | 4 | 5 | 6 | 4 | 5 | 8 | 14 | 10 |
Unrealized (loss) gain on investment in equity securities | - | - | - | - | - | - | - | - | 500,358 | -457,025 | 3,662 |
Gain (loss) on extinguishment of liabilities | - | - | - | - | - | - | - | - | - | -1,061,073 | -751,335 |
Other income (expense) | - | - | - | - | - | - | - | - | - | - | 7,849 |
Total other expense | 11,423 | -757,235 | -1,274,190 | -3,850,116 | 1 | -6,068,513 | -5,222,235 | -6,072,551 | -11,419,756 | -15,968,339 | -11,178,389 |
Net loss | -3,450,205 | -4,084,427 | -4,612,540 | -7,415,298 | -2,706,984 | -10,715,561 | -9,699,318 | -11,660,917 | -16,005,543 | -20,153,486 | -16,076,678 |
Deemed dividends on beneficial conversion feature | - | - | - | - | - | - | - | - | - | 873,798 | - |
Preferred stock dividends | 950,010 | 1 | 2 | 23,194 | - | - | - | - | 2 | 2 | 2 |
Net loss attributable to common shareholders | -4,400,215 | -5,247,449 | -6,251,726 | -7,438,492 | -2,706,984 | - | -23,473,150 | -15,868,083 | -17,584,710 | -22,685,459 | -17,803,953 |
Basic and diluted net loss per share attributable to common shareholders | - | - | - | - | - | - | - | - | - | - | -1.61 |